Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway

International Journal of Cancer

Volumn 137, Issue 6, 2015, Pages 1258-1268

  Ito, Miki ^a   Kanno, Shinichi ^a   Nosho, Katsuhiko ^a   Sukawa, Yasutaka ^b   Mitsuhashi, Kei ^a   Kurihara, Hiroyoshi ^a   Igarashi, Hisayoshi ^a   Takahashi, Taiga ^a   Tachibana, Mami ^a   Takahashi, Hiroaki ^c   Yoshii, Shinji ^d   Takenouchi, Toshinao ^c   Hasegawa, Tadashi ^a   Okita, Kenji ^a   Hirata, Koichi ^a   Maruyama, Reo ^a   Suzuki, Hiromu ^a   Imai, Kohzoh ^e   Yamamoto, Hiroyuki ^f   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c KEIYUKAI SAPPORO HOSPITAL   (Japan)

^d Sapporo Medical Center   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BRAF; colon polyp; colorectum; dysplasia; Fusobacterium; KRAS; microbiome; miR 31; MLH1; serrated neoplasia pathway

Indexed keywords

MICRORNA 31; MICRORNA; MIRN31 MICRORNA, HUMAN;

AGED; ARTICLE; CECUM; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; CPG ISLAND METHYLATOR PHENOTYPE; DISEASE ASSOCIATION; FEMALE; FUSOBACTERIUM NUCLEATUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RECTUM ADENOMA; SIGMOID; TRADITIONAL SERRATED ADENOMA; CARCINOGENESIS; COLON; COLORECTAL TUMOR; CPG ISLAND; DNA METHYLATION; FUSOBACTERIUM INFECTION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY;

AGED; CARCINOGENESIS; CECUM; COLON; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; HUMANS; MALE; MICRORNAS; MICROSATELLITE INSTABILITY;

EID: 84936847682     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29488     Document Type: Article

References (50)

1. Yamauchi M, Morikawa T, Kuchiba A, et al., Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012; 61: 847-54.
2. Ogino S, Chan AT, Fuchs CS, et al., Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397-411.
3. Yamauchi M, Lochhead P, Morikawa T, et al., Colorectal cancer: a tale of two sides or a continuum? Gut 2012; 61: 794-7.
4. Clemente JC, Ursell LK, Parfrey LW, et al., The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-70.
5. Cho I, Blaser MJ,. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13: 260-70.
6. Ursell LK, Haiser HJ, Van Treuren W, et al., The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014; 146: 1470-6.
7. Kostic AD, Chun E, Robertson L, et al., Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-15.
8. Castellarin M, Warren RL, Freeman JD, et al., Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306.
9. Sheikhi M, Gustafsson A, Jarstrand C,. Cytokine, elastase and oxygen radical release by fusobacterium nucleatum-activated leukocytes: a possible pathogenic factor in periodontitis. J Clin Periodontol 2000; 27: 758-62.
10. Park SR, Kim DJ, Han SH, et al., Diverse Toll-like receptors mediate cytokine production by fusobacterium nucleatum and aggregatibacter actinomycetemcomitans in macrophages. Infect Immun 2014; 82: 1914-20.
11. Rubinstein MR, Wang X, Liu W, et al., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013; 14: 195-206.
12. Flanagan L, Schmid J, Ebert M, et al., Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 2014; 33: 1381-90.
13. Tahara T, Yamamoto E, Suzuki H, et al., Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res 2014; 74: 1311-8.
14. Sears CL, Garrett WS,. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014; 15: 317-28.
15. Elinav E, Nowarski R, Thaiss CA, et al., Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13: 759-71.
16. Schwabe RF, Jobin C,. The microbiome and cancer. Nat Rev Cancer 2013; 13: 800-12.
17. Abreu MT, Peek RM Jr., Gastrointestinal malignancy and the microbiome. Gastroenterology 2014; 146: 1534-46 e3.
18. Conesa-Zamora P, Garcia-Solano J, Garcia-Garcia F, et al., Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 2013; 132: 297-307.
19. Dawson H, Galvan JA, Helbling M, et al., Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG island methylator phenotype and mismatch repair-deficiency. Int J Cancer 2014; 134: 2342-51.
20. Naito T, Nosho K, Ito M, et al., IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol 2014; 20: 10050-61.
21. Ito M, Mitsuhashi K, Igarashi H, et al., MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Int J Cancer 2014; 135: 2507-15.
22. Rosty C, Hewett DG, Brown IS, et al., Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol 2013; 48: 287-302.
23. Rex DK, Ahnen DJ, Baron JA, et al., Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315-29; quiz 4, 30.
24. Fujita K, Yamamoto H, Matsumoto T, et al., Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 2011; 35: 295-304.
25. Leggett B, Whitehall V,. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-100.
26. Bettington M, Walker N, Clouston A, et al., The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-86.
27. Gaiser T, Meinhardt S, Hirsch D, et al., Molecular patterns in the evolution of serrated lesion of the colorectum. Int J Cancer 2013; 132: 1800-10.
28. Bosman FT, World Health Organization. International Agency for Research on Cancer. WHO classification of tumours of the digestive system, 4th ed. Lyon: International Agency for Research on Cancer, 2010.
29. Goldstein NS,. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol 2006; 125: 132-45.
30. Kriegl L, Neumann J, Vieth M, et al., Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol 2011; 24: 1015-22.
31. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, et al., Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol Med Microbiol 2005; 45: 191-9.
32. Mitsuhashi K, Nosho K, Sukawa Y, et al., Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget, in press.
33. Nosho K, Igarashi H, Nojima M, et al., Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway. Carcinogenesis 2014; 35: 776-83.
34. Nosho K, Kure S, Irahara N, et al., A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609-20 e1-3.
35. Ogino S, Kawasaki T, Brahmandam M, et al., Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006; 8: 209-17.
36. Signat B, Roques C, Poulet P, et al., Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 2011; 13: 25-36.
37. Swidsinski A, Dorffel Y, Loening-Baucke V, et al., Acute appendicitis is characterised by local invasion with fusobacterium nucleatum/necrophorum. Gut 2011; 60: 34-40.
38. Strauss J, White A, Ambrose C, et al., Phenotypic and genotypic analyses of clinical fusobacterium nucleatum and fusobacterium periodonticum isolates from the human gut. Anaerobe 2008; 14: 301-9.
39. Neut C, Bulois P, Desreumaux P, et al., Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for crohn's disease. Am J Gastroenterol 2002; 97: 939-46.
40. Schetter AJ, Heegaard NH, Harris CC,. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31: 37-49.
41. Fleisher AS, Esteller M, Harpaz N, et al., Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000; 60: 4864-8.
42. Tahara T, Yamamoto E, Madireddi P, et al., Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. Gastroenterology 2014; 146: 530-38 e5.
43. Iacopetta B,. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-8.
44. Papagiorgis P,. Colorectal cancer: dichotomous or continuum model? Perhaps, a combination of both. Gut 2013; 62: 1519-20.
45. Anderson JC, Swede H, Rustagi T, et al., Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control 2012; 23: 355-61.
46. Lu FI, van Niekerk de W, Owen D, et al., Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010; 34: 927-34.
47. McCoy AN, Araujo-Perez F, Azcarate-Peril A, et al., Fusobacterium is associated with colorectal adenomas. PLoS One 2013; 8: e53653
48. Oue N, Anami K, Schetter AJ, et al., High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer 2014; 134: 1926-34.
49. Virtue A, Wang H, Yang XF,. MicroRNAs and toll-like receptor/interleukin-1 receptor signaling. J Hematol Oncol 2012; 5: 66
50. Honda T, Takahashi N, Miyauchi S, et al., Porphyromonas gingivalis lipopolysaccharide induces miR-146a without altering the production of inflammatory cytokines. Biochem Biophys Res Commun 2012; 420: 918-25.